Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | FDPS | P14324 | 2/20 | 0.38 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7076777 | 0.82 | FDPS (0.51) | CYP19A1FDPSALOX15TAAR1 | |
| SCHEMBL6090949 | 0.81 | CYP19A1 (0.64) | CYP19A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL3403575 | 0.80 | — | — | |
| SCHEMBL11535106 | 0.78 | CYP19A1 (0.70) | CYP19A1RAB9A | |
| SCHEMBL11531968 | 0.78 | CYP19A1 (1.00) | CYP19A1 | |
| SCHEMBL11533235 | 0.78 | CYP19A1 (0.70) | CYP19A1RAB9A | |
| SCHEMBL11540370 | 0.78 | CYP19A1 (0.70) | CYP19A1ALDH1A1SMN1; SMN2NISCHKDM4E | |
| Hydrochloric Acid SCHEMBL11532663 | 0.77 | CYP19A1 (0.68) | CYP19A1NISCHRAB9ATAAR1 | |
| SCHEMBL27536537 | 0.76 | — | — | |
| SCHEMBL8752315 | 0.75 | CYP19A1 (0.49) | CYP19A1ALDH1A1SMN1; SMN2FDPSKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150031600-A1 | DESIGNED BIOSURFACTANTS, THEIR MANUFACTURE, PURIFICATION AND USE | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-01-29 | — | — | US | disclosed |
| EP-1858914-B1 | PEPTIDE NETWORKS | UNIV QUEENSLAND (AU) | 2013-12-04 | — | — | EP | disclosed |
| US-20130085188-A1 | PEPTIDE NETWORKS | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-04-04 | — | — | US | disclosed |
| WO-2012079125-A1 | DESIGNED BIOSURFACTANTS, THEIR MANUFACTURE, PURIFICATION AND USE | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-06-21 | — | — | WO | disclosed |
| US-20120046444-A1 | PEPTIDE NETWORKS | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-02-23 | — | — | US | disclosed |
| US-8039582-B2 | Peptide networks | THE UNIVERSITY OF QUEENSLAND (AU) | 2011-10-18 | — | — | US | disclosed |
| US-7833331-B2 | Non-toxic corrosion-protection pigments based on cobalt | UNIVERSITY OF DAYTON (US) | 2010-11-16 | — | — | US | disclosed |
| US-7789958-B2 | Non-toxic corrosion-protection pigments based on manganese | UNIVERSITY OF DAYTON (US) | 2010-09-07 | — | — | US | disclosed |
| US-20100152420-A1 | PEPTIDE NETWORKS | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-06-17 | — | — | US | disclosed |
| US-20090163628-A1 | NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON COBALT | STURGILL JEFFREY ALLEN | 2009-06-25 | — | — | US | disclosed |
| US-20030234063-A1 | Non-toxic corrosion-protection conversion coats based on cobalt | DAYTON, UNIVERSITY OF | 2003-12-25 | — | — | US | disclosed |
| US-20030230363-A1 | Non-toxic corrosion-protection rinses and seals based on cobalt | UNIVERSITY OF DAYTON | 2003-12-18 | — | — | US | disclosed |
| WO-2003060192-A1 | NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060019-A1 | NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| US-5646296-A | POLYMERIZABLE BIS-IMIDAZOLYL COMPOUNDS; WATER TREATMENT | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-07-08 | — | — | US | disclosed |
| US-5637728-A | BIS-IMIDAZOLYL COMPOUNDS OR POLYMERIZABLE MONOMER; CHELATING AGENT, CURING AGENT; CORROSION RESISTANCE, PROTECTIVE COATINGS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-06-10 | — | — | US | disclosed |
| US-5605994-A | POLYMERS CONTAINING BIS-IMIDAZOLYL UNITS; METAL SCAVENGERS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-02-25 | — | — | US | disclosed |
| EP-0723543-A1 | METAL ION BINDING MONOMER AND POLYMER | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-07-31 | — | — | EP | disclosed |
| US-5455359-A | For chelation of heavy metals in waste water treatment | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-10-03 | — | — | US | disclosed |
| WO-1995009854-A1 | METAL ION BINDING MONOMER AND POLYMER | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046444-A1 | PEPTIDE NETWORKS | IAPP, MSN, FGB | CYP19A1 4254/4885ALDH1A1 4859/4885SMN1; SMN2 3462/4885 |
| US-20130085188-A1 | PEPTIDE NETWORKS | IAPP, MSN, FGB | CYP19A1 4254/4885ALDH1A1 4859/4885SMN1; SMN2 3462/4885 |
| US-20150031600-A1 | DESIGNED BIOSURFACTANTS, THEIR MANUFACTURE, PURIFICATION AND USE | PNISR, ASNS, ARGLU1 | CYP19A1 2209/4885ALDH1A1 4842/4885SMN1; SMN2 4205/4885 |
| US-20100152420-A1 | PEPTIDE NETWORKS | IAPP, MSN, FGB | CYP19A1 4254/4885ALDH1A1 4859/4885SMN1; SMN2 3462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.